Neurological Sequelae in Patients With Acute Carbon Monoxide Poisoning

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16+
SponsorThe First Hospital of Jilin University

About this trial

The purpose of this study is to access the clinical characteristics and risk factors for neurological sequelae after acute carbon monoxide poisoning.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patients present within 12 hours after acute carbon monoxide poisoning;

age older than 16 years.

Disqualifiers

pregnant women;

patients receive oxygen therapy before presentation;

have history of acute carbon monoxide poisoning within 1 year;

have been diagnosed any of the following disease: Parkinson disease; cognitive disorder, psychiatric disorders, sequelae of cerebral infarction or hemorrhage, chronic kidney disease and receive hemodialysis, congestive heart failure ( NYHA class III-IV)

Trial population

All the patients with acute carbon monoxide poisoning would be recruited from the First Hospital of Jilin University.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • No intervention

    Other intervention

    No intervention will be given

Treatment groups

1,250 Participants
are divided into 2 treatment groups
Group A: Non-NS ( Non-neurological sequelae) group1 intervention
Group B: NS (Neurological sequelae) group1 intervention

Trial outcomes

Primary outcomes

1

Changes of Mini-mental State Examination (MMSE) score at 6 weeks

Score ranges from 0 to 30, a lower score means a worse outcome.

Time frame
Changes of score from baseline to 6 weeks
2

Changes of Mini-mental State Examination (MMSE) score at 6 months

Score ranges from 0 to 30, a lower score means a worse outcome.

Time frame
Changes of score from baseline to 6 months
3

Changes of Mini-mental State Examination (MMSE) score at 12 months

Score ranges from 0 to 30, a lower score means a worse outcome.

Time frame
Changes of score from baseline to 12 months
4

Changes of Montreal cognitive assessment (MoCA)score at 6 weeks

Score ranges from 0 to 30, a lower score means a worse outcome.

Time frame
Changes of score from baseline to 6 weeks

Secondary outcomes

1

Rates of cardiovascular and cerebrovascular events

Cardiovascular and cerebrovascular events includes:cardiac arrest, myocardial infarction, cerebral hemorrhage, and cerebral infarction. A patient develops any of the former diseases during following up would be record as 1 event.

Time frame
through study completion, an average of 1 year
2

Rates of accidental injury

Accidental injuries may include accidental fall, fracture, traffic accident etc. A patient develops any of the former during following up would be record as 1 event.

Time frame
through study completion, an average of 1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: